| 1 |
34585713 | A pH-sensitive T7 peptide-decorated liposome system for HER2 inhibitor extracellular delivery: an application for the efficient suppression of HER2+ breast cancer. | 2021 Nov 3 |
1 |
| 2 |
32585059 | Characterization of Locally Excited and Charge-Transfer States of the Anticancer Drug Lapatinib by Ultrafast Spectroscopy and Computational Studies. | 2020 Dec 4 |
3 |
| 3 |
32707209 | pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment. | 2020 Oct 10 |
1 |
| 4 |
30590459 | Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors. | 2019 Aug 22 |
3 |
| 5 |
30611900 | Heterotelechelic polymer prodrug nanoparticles: Adaptability to different drug combinations and influence of the dual functionalization on the cytotoxicity. | 2019 Feb 10 |
1 |
| 6 |
27155465 | Design, synthesis and biological evaluation of novel HSP70 inhibitors: N, N'-disubstituted thiourea derivatives. | 2016 Aug 25 |
1 |
| 7 |
26199252 | [A Case of Effective Whole-Brain Irradiation and Lapatinib/Capecitabine Combination Therapy for HER2-Positive Breast Cancer with Multiple Brain Metastases]. | 2015 Jun |
1 |
| 8 |
18283037 | Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells. | 2008 Jun |
4 |